GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Caution] not approved anywhere. keep posts descriptive. — 23 comments in the full submission. View in context.
522
c/cagrilintide·submitted 22 days ago by u/pancreatitis_scare

[Caution] not approved anywhere. keep posts descriptive.

Cautionbranch of 6 comments

co-agonism. That is the whole post, but I will justify it. Everything else people worry about in c/vendorvetting is downstream of it. Titration speed, muscle cramps, the endless dose arguments — most of it resolves if you sort co-agonism out first, and almost nobody does. I say this having got it wrong for 15 months.…

Read the full submission and all 23 comments →

This branch

6 comments, started 21 days ago
u/rina_sobczak-27 points·21 days ago

Disagree. What you are describing is consistent with CagriSema, not with what you concluded.

replysharereportpermalink
u/georgi_chowdhury1 point·20 days ago

REDEFINE which arm?

replysharereportpermalink
u/runa_grimaldi1 point·21 days ago

long-acting amylin is co-agonism, different satiety profile

replysharereportpermalink
u/hedda_aguirre1 point·20 days ago

not approved anywhere, keep posts descriptive, not instructional

replysharereportpermalink
u/sequence_checkerresearch peptides1 point·20 days ago

amylin receptor distribution is different from GLP-1

replysharereportpermalink
u/hugo_pires1 point·20 days ago

the amylin agonist pool is small, community is satiety

replysharereportpermalink

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.